U.S. Markets close in 3 hrs 44 mins

GBT Technologies Inc. (GTCH)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0110-0.0002 (-1.79%)
As of 11:57AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0112
Open0.0110
BidN/A x N/A
AskN/A x N/A
Day's Range0.0107 - 0.0120
52 Week Range0.0090 - 1.4500
Volume977,753
Avg. Volume1,447,506
Market Cap2.556M
Beta (5Y Monthly)3.39
PE Ratio (TTM)N/A
EPS (TTM)-82.7830
Earnings DateMay 15, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GBT Tokenize Open Public Research Kirlian Electrophotography
    GlobeNewswire

    GBT Tokenize Open Public Research Kirlian Electrophotography

    Phase 1 : Hand image Phase 1 : Hand image Phase 1 : Body image Phase 1 : Body image Phase 1 : Body image - test3 Phase 1 : Body image - test3Phase I Update - Techniques ResearchSAN DIEGO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), announced as a further update to its press release issued November 12, 2020, that GBT Tokenize (“GBT/Tokenize”), its joint venture, started Phase I in the Kirlian Electrophotography imaging technique, potentially aimed for inclusion within its qTerm device. Kirlian photography is a series of techniques that are based on the phenomenon known as electrical coronal discharge. Images that are taken using these techniques present a colorful so-called aura, which can be interpreted in a variety of ways.The open research is focused on the efforts combining Kirlian imaging with the use of machine learning technology to possibly detect early disease symptoms. GBT/Tokenize is conducting experiments with a few advanced algorithms, one of them is a private derivative of the Genetic algorithm. The genetic algorithm is a method for solving both constrained and unconstrained optimization problems that are based on natural selection, the process that drives biological evolution. The algorithm is planned to find pattern similarities in Kirlian images in living tissues in order to categorize potential health related issues. Kirlian imaging produces typical features such as graphical protuberances, halos, and discharge patterns, which can be analyzed by an AI computer program as unique patterns, and categorized as possible criteria for early symptoms identification.  GBT/Tokenize is conducting experiments with advanced algorithms and methods to analyze energy fields generated by living organs at set periods. These image's auras will be graphically analyzed to determine patterns that are associated with possible health related symptoms. GBT/Tokenize plans to develop neural network based pattern recognition technology to detect-and-associate unique patterns with related, possible health issues. The research is planned to be conducted over a period of one year and based on its results the company will evaluate the feasibility of implementation of such techniques within its qTerm human vitals product in order to provide further health information for the user's benefit. "We are going to look deeper into Kirilian electrophotography science, trying to identify the possibility of detecting early disease symptoms. Kirlian images of a living tissue during various intervals may exhibit some similarities. If we could graphically analyze these images using machine learning technology, reaching some consistent conclusions, then we may find a way to find possible early health issue identification" stated Danny Rittman, GBT’s CTO.  "We intend to analyze and measure Kirilian images to find unique patterns that may be associated with early symptoms. We will look for full and partial similarities, repetitions, or atypical auras patterns. We will be using AI computing power to detect dynamic images changes as each image will be digitized using high resolution scanning. Here the power of huge data analysis will be extremely beneficial. We plan to implement interactive algorithms to analyze on-the-fly out-of-boundaries patterns to get a comparative representation between the images. The challenging part will be to associate the human body's various radiations graphical representation, with health related issues. For this purpose, we plan to use our AI, vast data analysis capabilities, trying to assemble a reliable algorithm to create an associative table that will relate patterns to a possible onset disease. Upon reaching conclusions we will evaluate the potential implementation of this technology within our qTerm device to further advice users about their health” continued Dr. Rittman.  Actual GBT/Tokenize’s Phase I imaging (for presentation purposes only) are available at:https://www.globenewswire.com/NewsRoom/AttachmentNg/475d6f41-3737-40c8-b83e-89cf23d2f1d3 https://www.globenewswire.com/NewsRoom/AttachmentNg/6d35d0f1-1c13-4993-8c7c-a44c3cc20f00 https://www.globenewswire.com/NewsRoom/AttachmentNg/7e4996dd-94b8-46cf-a6a7-144b5c3570c8Forward-Looking StatementsCertain statements contained in this press release may constitute "forward-looking statements".  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.  The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.Contact: Dr. Danny Rittman, CTO press@gopherprotocol.com

  • GBT's Patent for 3D Monolithic, Multi-Dimensional/Plane, Memory Structure - Integrated Circuits – Granted
    GlobeNewswire

    GBT's Patent for 3D Monolithic, Multi-Dimensional/Plane, Memory Structure - Integrated Circuits – Granted

    SAN DIEGO, Nov. 24, 2020 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), announced as continuance update to its press release from October 29, 2020, that its 3D microchip patent received a grant date as of December 1, 2020 by the United States Patent and Trademark Office (“USPTO”); U.S. Patent No. 10,854,763. The Company filed for this patent on March 5, 2019. The invention relates to the field of integrated circuit (IC) silicon structure, and more particularly to multi-dimensional, multi-planar microchips. This patent covers GBT's futuristic integrated circuit technology which introduces new methods for microchip's manufacturing. The concept presents a new die structure and orientation. The Company believes that the new methods are efficient for all manufacturing nodes and especially for deep nanometer ranges. The technology enables the manufacturing of more transistors on a silicon wafer in order to place more circuits/features on a die. The new manufacturing architecture enables larger designs within smaller areas and significantly increases the silicon yield. The invention supports analog, RF, digital, MIXED and MEMS designs. We believe that it has the potential to revolutionize integrated circuits manufacturing and packaging, enabling huge chips on affordable silicon areas. It may be especially significant when it comes to heavily area-dependent ICs, for example memory chips, MEMS (Micro-Electro-Mechanical Systems) and micro solar cells.When it comes to these types of microchips, silicon area is crucial and every micron is important. The new approach will enable the manufacturing of much larger chips within affordable areas. A three-dimensional integrated circuit is a metal-oxide semiconductor (MOS) integrated circuit, manufactured by stacking silicon dies and electrically interconnecting them vertically. GBT's invention goes beyond 3D concept with multi-plane silicon structures, for example honeycomb, hexagonal and further multi-planetary structures, with the goal of increasing silicon surface area. The patent covers silicon interconnection not only vertically but in a multi planar way which opens an entire world of possibilities maximizing silicon area. Manufacturing these types of structures will enable the design of chips with multi-trillion transistors on die, creating new horizons for our entire electronics world. Few examples of areas that will be significantly enhanced are flash memories, GPUs, CPUs, displays, micro-solar cells panels, RF, and MEMS. "We are glad to announce that we will be granted our multi-planer microchip patent on December 1, 2020," said Danny Rittman, GBT’s CTO.  "By manufacturing honeycomb, hexagonal and other multi planer structural shapes die, we believe IC design houses will be able to increase their silicon surface for transistors. Especially when it comes to memory circuits, silicon real-estate is a key factor. As more we can place on the silicon, as better, given reasonable, affordable die size. We believe the invention will enable to design and manufacture gigantic chips for all design processes including advanced nodes like 10nm, 7nm, 5nm and below."Forward-Looking StatementsCertain statements contained in this press release may constitute "forward-looking statements".  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.  The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.Contact: Dr. Danny Rittman, CTO press@gopherprotocol.com

  • qTerm - Ambient Temperature Measurement Feature Added
    GlobeNewswire

    qTerm - Ambient Temperature Measurement Feature Added

    SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), announced that its joint Venture, GBT Tokenize Corp., is enhancing qTerm vitals device, adding an ambient temperature sensing system which the Company intends to include in its first version. This feature is designed to sense the user's surroundings temperature, as a reference for accuracy.  qTerm will let the user know in the event the ambient temperature is not 'optimum' for data measurement. In case that the user is in an outdoors condition that will affect the measurement accuracy, it is designed to provide an alert. In hot or cold geographical regions, the user's skin temperature may be elevated/declined due to the surrounding temperature. This may distort the measured data. qTerm will be able to detect and alert for such probability. Another device is intended to be added to qTerm in order to detect extreme ambient temperature and advise the user to take measurements in a more neutral or climate controlled area. A supporting firmware code will work in conjunction with this feature and an additional alerting system is planned to be embedded within the accompanied mobile app. An advanced software module will be developed for the backend program to geographically detect the user's environment temperature according to his/her location. qTerm will include a high-precision digital temperature sensor with a low power consumption that will be used in a 'no-contact' fashion. The sensor is designed to measure temperatures with an accuracy of up to ±0.1°C across the range of -20°C and 50°C with no calibration. This data will be used as a confirmation reference, comparing for the actual taken measurement temperature to the reported resources, together advising the user about potential inaccuracies and switching to a better environment for optimum data results. An ambient temperature is the actual temperature of the air in any particular location, as measured by a thermal device and plays a significant factor in a human body temperature measurement. This feature is planned to be included within the first release of qTerm.    "Imagine a qTerm user that is currently located in Phoenix, AZ outdoors during summer time. The outdoor temperature will cause the user's skin temperature to be elevated and, therefore, the data reading will be inaccurate. qTerm will alert about taking the measurement in an area of extreme surrounding temperatures, advising to go into a more climate controlled zone like indoors environment," said Danny Rittman, GBT’s CTO. "Another example is taking the temperature in New York City in the outdoors. The user's finger tip will be cold which will cause inaccurate results. We are implementing another circuit within our qTerm device to measure the user's environment temperature, alerting in case of extremes. In addition, our backend program will verify the measured ambient temperature, taking the data from online resources, according to the user's location. Together with the electronic circuit, which is a high-precision digital temperature sensor actual results, qTerm will reach a conclusion about alerting the user or not. A supporting code will be developed in order to create a pre-temp measurement procedure to ensure optimum ambient temperature before checking the body temperature. We focus on accuracy and reliability of human vitals and would like to ensure optimum conditions for data measurement. Additionally, we may use the ambient data at the 'system' level for further analysis purposes.  qTerm AI software will be using the data to further analyze and record the user's information for future use," continued Danny Rittman, GBT’s CTO.Forward-Looking StatementsCertain statements contained in this press release may constitute "forward-looking statements".  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.  The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.Contact: Dr. Danny Rittman, CTO GBT Technologies Inc. Press@gopherprotocol.com